Gabelli Merger Plus+ Trust plc Update on Share Purchase Offer
Retrieved on:
Wednesday, August 17, 2022
Banking, Professional Services, Finance, Investment, Board, Loyalty, Financial services, Person, Registered, Circular, EU, RNS, News, Regulation, Financial Services and Markets Act 2000, Securities Act of 1933, Sale, GMP, Nature, Business Process Framework (eTOM), Portfolio manager, United Kingdom, LTD, Offering circular, LLC, European Economic Area, Compliance, Income, Finance, Trustee, Mario Gabelli, Time, Mass meeting, Common stock, Review, Company, Prognosis, Section 21, FSMA, General officer, Forward, Admission, Completeness, EEA, Pharmaceutical industry, Security (finance), Management, Risk management, Property management, Real estate, Bank, Directive 2014/65/EU
Gabelli Funds, LLC, the investment adviser of Gabelli Merger Plus+ Trust plc (the Company), is providing shareholders, as general information, certain details of the Companys tender offer to purchase certain Ordinary Shares (Offer) in advance of publication of the Offering Circular (Circular), and follows the Companys March 23, 2022 announcement.
Key Points:
- Gabelli Funds, LLC, the investment adviser of Gabelli Merger Plus+ Trust plc (the Company), is providing shareholders, as general information, certain details of the Companys tender offer to purchase certain Ordinary Shares (Offer) in advance of publication of the Offering Circular (Circular), and follows the Companys March 23, 2022 announcement.
- Shareholders should contact Gabelli Funds at [email protected] to ensure their necessary evidentiary supporting materials are satisfactory and for any general assistance.
- The Gabelli Merger Plus+ Trust (GMP) was launched in July 2017 to access Gabellis long term efforts in merger investing.
- The investment backdrop for the Gabelli Merger Plus+ Trust is robust and positively oriented for returns.